Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ChemoPower

Explore full profile

Software for rapid, accurate chemical composition analysis

Singapore
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ChemoPower and the history behind them.

About ChemoPower

ChemoPower Technology Pte Ltd is a Singaporean company founded in 2013 that develops software for chemical analysis. The company was founded by Dr. George Zhang, who serves as the CEO and has a multi-disciplinary background in chemistry, software programming, and engineering. His expertise helped create the company's core technologies.

The company's main offering is an online chemical analysis system, complemented by products like SmartDalton™, MoleculeDB, and SmartNIST. This software platform uses proprietary mathematical models and chemometrics to analyze experimental data from Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) instruments. Its key feature is the ability to deconvolute mixed chemical signals and identify individual compounds, including trace and previously unknown components, without requiring prior information or physical sample separation. This process is significantly faster—up to 100 times—and more cost-effective than traditional methods. The software is compatible with instruments from major manufacturers and is designed to be user-friendly, allowing technicians without specialized expertise to perform complex analyses.

ChemoPower targets a broad range of industries, including pharmaceuticals, traditional medicine, environmental science, and food safety, for applications such as quality assurance and control. A primary strategic focus is the modernization of Traditional Medicine (TM) through evidence-based science. The company aims to create a comprehensive, globally recognized databank of chemical compositions for TM, positioning itself as a leader in TM quality standards and the discovery of new active ingredients. To advance this goal, ChemoPower has engaged in collaborations with government bodies and enterprises, including a joint laboratory project with Singapore's A*STAR. The company has received funding from sources such as an Early Stage VC round in 2016 and a grant from the Singapore government in 2020. Having expanded into China, ChemoPower is increasing its presence in both developed and emerging markets.

Source: Dealroom company data

At a glance

Headquarters
Singapore
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇸🇬 Singapore HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ChemoPower on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ChemoPower on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.